SI2729473T1 - Derivati karboksilne kisline z oksazolo(5,4-B)piridinskim obročem - Google Patents

Derivati karboksilne kisline z oksazolo(5,4-B)piridinskim obročem

Info

Publication number
SI2729473T1
SI2729473T1 SI201230458T SI201230458T SI2729473T1 SI 2729473 T1 SI2729473 T1 SI 2729473T1 SI 201230458 T SI201230458 T SI 201230458T SI 201230458 T SI201230458 T SI 201230458T SI 2729473 T1 SI2729473 T1 SI 2729473T1
Authority
SI
Slovenia
Prior art keywords
oxazolo
carboxylic acid
acid derivatives
pyridine ring
pyridine
Prior art date
Application number
SI201230458T
Other languages
English (en)
Inventor
Dieter Kadereit
Matthias Schafer
Stephanie Hachtel
Thomas Huebschle
Katrin Hiss
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of SI2729473T1 publication Critical patent/SI2729473T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI201230458T 2011-07-07 2012-07-06 Derivati karboksilne kisline z oksazolo(5,4-B)piridinskim obročem SI2729473T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11305877 2011-07-07
EP12305525 2012-05-11
EP12733131.2A EP2729473B1 (de) 2011-07-07 2012-07-06 Carbonsäurederivate mit einem oxazolo[5,4-b]pyridinring
PCT/EP2012/063297 WO2013004826A1 (de) 2011-07-07 2012-07-06 Carbonsäurederivate mit einem oxazolo[5,4-b]pyridinring

Publications (1)

Publication Number Publication Date
SI2729473T1 true SI2729473T1 (sl) 2016-03-31

Family

ID=46466551

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201230458T SI2729473T1 (sl) 2011-07-07 2012-07-06 Derivati karboksilne kisline z oksazolo(5,4-B)piridinskim obročem

Country Status (21)

Country Link
US (1) US8580816B2 (sl)
EP (1) EP2729473B1 (sl)
JP (1) JP5984925B2 (sl)
KR (1) KR20140061384A (sl)
CN (1) CN103781790B (sl)
AU (1) AU2012280206B2 (sl)
BR (1) BR112014000100A2 (sl)
CA (1) CA2841220C (sl)
CY (1) CY1117390T1 (sl)
DK (1) DK2729473T3 (sl)
ES (1) ES2562852T3 (sl)
HK (1) HK1192239A1 (sl)
HR (1) HRP20160167T1 (sl)
HU (1) HUE026432T2 (sl)
MX (1) MX365931B (sl)
MY (1) MY164133A (sl)
PL (1) PL2729473T3 (sl)
PT (1) PT2729473E (sl)
RU (1) RU2609002C2 (sl)
SI (1) SI2729473T1 (sl)
WO (1) WO2013004826A1 (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8907093B2 (en) * 2011-07-07 2014-12-09 Sanofi Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring
US9321787B2 (en) 2011-07-07 2016-04-26 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO143535C (no) * 1972-06-14 1981-03-04 Merck & Co Inc Analogifremgangsmaate ved fremstilling av terapeutisk aktive oxazolopyridiner
DK1390371T3 (da) * 2001-05-14 2006-06-19 Novartis Ag Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer
US7060697B2 (en) * 2003-05-19 2006-06-13 Irm Llc Immunosuppressant compounds and compositions
EP1965807A4 (en) * 2005-11-23 2010-10-27 Epix Delaware Inc S1P RECEPTOR MODULATING COMPOUNDS AND THEIR USE
EP1900729A1 (en) * 2006-09-15 2008-03-19 Novartis AG Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors
EP2364976B1 (en) 2007-03-21 2014-10-08 EPIX Pharmaceuticals, Inc. S1P receptor modulating compounds and use thereof
JP2011524864A (ja) 2008-05-30 2011-09-08 メルク・シャープ・エンド・ドーム・コーポレイション 新規な置換されたアザベンゾオキサゾール
TW201000099A (en) 2008-06-20 2010-01-01 Amgen Inc S1P1 receptor agonists and use thereof
EP2318415B1 (en) 2008-07-15 2013-02-20 Sanofi Oxazolopyrimidines as edg-1 receptor agonists
US8907093B2 (en) * 2011-07-07 2014-12-09 Sanofi Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring

Also Published As

Publication number Publication date
HRP20160167T1 (hr) 2016-03-11
RU2609002C2 (ru) 2017-01-30
CN103781790B (zh) 2016-04-27
EP2729473B1 (de) 2015-11-25
EP2729473A1 (de) 2014-05-14
DK2729473T3 (en) 2016-02-29
CN103781790A (zh) 2014-05-07
KR20140061384A (ko) 2014-05-21
PL2729473T3 (pl) 2016-05-31
RU2014104232A (ru) 2015-08-20
BR112014000100A2 (pt) 2017-01-10
CA2841220C (en) 2019-07-30
MY164133A (en) 2017-11-30
CA2841220A1 (en) 2013-01-10
HUE026432T2 (en) 2016-05-30
MX365931B (es) 2019-06-20
ES2562852T3 (es) 2016-03-08
AU2012280206A1 (en) 2014-01-23
US8580816B2 (en) 2013-11-12
PT2729473E (pt) 2016-03-22
JP2014518247A (ja) 2014-07-28
WO2013004826A1 (de) 2013-01-10
HK1192239A1 (zh) 2014-08-15
CY1117390T1 (el) 2017-04-26
AU2012280206B2 (en) 2016-07-28
MX2014000024A (es) 2014-02-27
JP5984925B2 (ja) 2016-09-06
US20130023557A1 (en) 2013-01-24

Similar Documents

Publication Publication Date Title
IL227496B (en) Pyrazolo[4,3–b]pyridines are converted as drugs
HK1226394A1 (zh) 7-氮雜吲哚衍生物
ZA201307783B (en) Tri-and tetracylic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent
IL234485A (en) Compounds based on imidazo [2,1 – b] pyridazine
HK1190393A1 (zh) 作為抗寄生物劑的螺環異噁唑啉衍生物
EP2634186A4 (en) naphthyridine
ZA201206630B (en) Hetaryl-[1,8]naphthyridine derivatives
HK1202288A1 (en) 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives 2---35-
IL232717B (en) 3-cyanoaryl-h1-pyrrolo[b-3,2]pyridine derivatives
PL2531505T3 (pl) Sposób wytwarzania kompleksów 3,7-diaza-bicyklo[3.3.1]nonanu z metalami
IL221479A0 (en) Triazolo [4,5-b] pyridin derivatives
ZA201301313B (en) Herbicidal isoxazolo[5,4-b]pyridines
ZA201307511B (en) Pyrido [2,3-b] pyrazine derivatives and their therapeutical uses
EP2558094A4 (en) PYRIDONE DERIVATIVES
SG11201408816QA (en) 3-(PYRAZOLYL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS
DK2523958T3 (da) Carboxylsyrederivater med en 2,5,7-substitueret oxazolopyrimidinring
HK1192240A1 (en) Carboxylic acid derivatives with an oxazolo[5,4-d]pyrimidine ring [54-d]
EP2565194A4 (en) Imidazo [1,2-A] pyridine
HK1208029A1 (en) Imidazopyridine derivatives
SI2729473T1 (sl) Derivati karboksilne kisline z oksazolo(5,4-B)piridinskim obročem
BR112013013282A2 (pt) compostos de oxazolo[5,4-b]piridin-5-ila
IL235300A0 (en) A process for the preparation of naphthyridine hist
HK1192237A1 (en) Carboxylic acid derivatives with an oxazolo[5,4-d]pyrimidine ring [54-d]
PL390846A1 (pl) Pochodne 5,11-dimetylo-5H-indolo[2,3-b]chinoliny
GB201221462D0 (en) Novel isothiazolo[5,4-b]pyridines